BIOVIT — Bio Vitos Pharma AB Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln
Brief: Bio Vitos Pharma Enters Strategic, Long-Term IR Partnership With Börsjakten Holding
Brief: Bio Vitos Pharma To Divest Business, Purchase Price SEK 400,000
Brief: Bio Vitos CEO Jesper Birgemo Resigns
Brief: Bio Vitos Pharma Finalises Transaction In Accordance With Resolution At EGM, Issues New Shares
Brief: Bio Vitos Pharma Q4 Pre-Tax Loss Widens To SEK 5.1 Mln
Brief: Bio Vitos Pharma Gets Patent For Succifer
Brief: Hemcheck Sweden Appoints Jesper Birgemo As CEO
Brief: Hemcheck Sweden To Change Name To Bio Vitos Pharma AB
Brief: Hemcheck Sweden Q3 Loss After Items Narrows To SEK 3.4 Mln
Brief: Hemcheck Extends Subscription Period In Deal With Bio Vitos
Brief: Hemcheck Sweden Signs Letter Of Intent To Acquire Additional Ip Rights
Brief: Hemcheck Sweden Gets Additional Order From French Distributor
Brief: Hemcheck Sweden Q2 Pre-Tax Loss Loss Narrows To SEK 1.2 Mln
Brief: Hemcheck Sweden Further Extends Subscription Period In Deal With Bio Vitos
Brief: Hemcheck Sweden Signs Credit Facility Of SEK 5 Mln